Targeted Therapies for Locally Advanced or Metastatic EGFR-mutated NSCLC

home / case-based-digest / targeted-therapies-for-locally-advanced-or-metastatic-egfr-mutated-nsclc

As part of the Community Case Forum series, key opinion leaders and participants discuss the evolution of targeted therapies for the treatment of locally advanced or metastatic EGFR-mutated NSCLC.

yellow background with an outline drawing of lungs

Evaluating Targeted Therapies: MARIPOSA Trial Aids APPs in Treating EGFR+ NSCLC

Kristie L. Kahl

January 3rd 2025

Beth Sandy, MSN, CRNP, FAPO, led a discussion on EGFR-mutated non-small cell lung cancer, focusing on targeted therapies for those with advanced, treatment-naïve disease.